The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.

ABSTRACT:

SUBMITTER: Osataphan S 

PROVIDER: S-EPMC12410534 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature